News
WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...
The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...
Researchers wanted to provide insight into the relative clinical value of Apretude and lenacapavir compared with no ...
KIGALI, July 17 (Xinhua) -- Health experts are calling on governments around the world to increase funding for HIV research and community-led responses, warning that current funding cuts risk ...
The US Senate has moved to spare the world’s biggest HIV treatment and prevention programme – which funds drugs and research in more than 50 countries – from $400m (£298m) of aid cuts imposed by ...
Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...
Let us refresh the old gold Buddhist tale of The Quail and the Net: ldquo;Long ago a flock of quails lived in a forest .
19h
Medpage Today on MSNInvestigational Once-Weekly ART Combo Maintained Viral Suppression in HIVAn investigational once-weekly oral antiretroviral therapy (ART) combination effectively maintained viral suppression in ...
1d
AllAfrica on MSNThree Studies Uncover Safer, More Effective HIV Treatment Options for Older People in AfricaFindings from Kenya by CEMA at the International AIDS Society Conference on HIV ScienceRwanda, July 15, 2025-- The University of Nairobi, Center for Epidemiological Modelling and Analysis (CEMA), has ...
The U.S. Senate has opened debate on a $9 billion rescission bill to claw back foreign aid and other funding not aligned with ...
The World Health Organization (WHO) chief on Monday called on world leaders to prioritize HIV prevention and embrace ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results